According to a new report, published by KBV research, The Global Research-grade Proteins Market size is expected to reach $2.5 Billion by 2030, rising at a market growth of 15.2% CAGR during the forecast period.
The Bacterial Cells segment is experiencing a CAGR of 14.9% during (2023 - 2030). Bacterial cells, such as Escherichia coli (E. coli), offer several advantages for protein production. They are cost-effective, easy to manipulate genetically, and can generate high protein yields quickly. This scalability is particularly crucial in meeting the growing demand for research-grade proteins, including enzymes, antibodies, and recombinant proteins, which are essential in various fields such as biotechnology, pharmaceuticals, and academia.
The Cytokines & Growth Factors segment is generating the highest revenue share in the Global Research-grade Proteins Market, by Product in 2022; thereby, achieving a market value of $513.9 million by 2030. These proteins are primarily used in biomedical research and drug development, particularly in understanding diseases, identifying potential therapeutic targets, and developing drugs or therapies to modulate specific biological processes.
The Academic & Research Institutes segment is registering a CAGR of 15.5% during (2023 - 2030). Academic and research institutes are often at the forefront of protein discovery. They conduct fundamental research to identify novel proteins and study their functions, structures, and interactions. This research contributes to expanding the catalog of available research-grade proteins, which is invaluable for the scientific community. Some research institutes have the infrastructure and expertise to produce custom or specialized research-grade proteins.
The North America region dominated the Global Research-grade Proteins Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.0 billion by 2030. The Europe region is poised to grow at a CAGR of 15% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 16.1% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/research-grade-proteins-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Abcam Plc, Miltenyi Biotech B.V. & Co. KG, Genscript Biotech Corporation, Bio-Techne Corporation, Proteintech Group, Inc., AcroBiosystems INC., Sino Biologicals, Inc. and ProSpec-Tany TechnoGene Ltd. and New England Biolabs, Inc.
By Host Cell
By Product
By End-use
By Geography
Companies Profiled
Unique Offerings 
